David J. Foster

Angiotech BioMaterials Corp. develops tissue repair and regeneration technology. The company was founded by David J. Foster in June 1997 and is headquartered in Palo Alto, CA.

VaxGen, Inc. is a biopharmaceutical company, owns a state-of-the-art biopharmaceutical manufacturing facility that can be used to make cell culture or microbial biologic products. The company has ended all product development activities and sold or otherwise terminated its drug development programs. It is seeking to maximize the value of its remaining tangible and intangible assets through a transaction or series of transactions, including the sale of the manufacturing facility. The company was founded on November 01, 1995 and is headquartered in South San Francisco, CA.

Argonaut Technologies, Inc. develops, manufactures, and markets products that enable chemists to use high speed parallel synthesis in the development of new drugs

diaDexus is a privately held biotechnology company that is focused on the discovery, development and commercialization of novel, patent protected diagnostic products with high clinical value. diaDexus makes a difference by developing innovative products with clinical value to address significant unmet medical needs in the cardiovascular field.

NovaRay, Inc. operates as a medical imaging firm. It develops digital cardiac x-ray technology. The company was founded in 2005 and is headquartered in Newark, CA.

NovaRay Medical, Inc. operates as a medical imaging company that focuses on developing innovations in proprietary digital cardiac x-ray technology. The company was founded by Marc Chester Whyte in June 2005 and is headquartered in Newark, CA.

Diadexus, Inc. engages in the research, development, and commercialization of pharmaceutical products. Its portfolio intends to treat cardiovascular diseases. The company was founded on November 27, 1995 and is headquartered in South San Francisco, CA.